(Q44037625)

29 November 2017

title

Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal (English)

1 reference

inflammatory bowel diseases

29 November 2017

main subject

0 references

inflammation

0 references

author name string

F S P Regadas

1

1 reference

29 November 2017

R A Pinto

2

1 reference

29 November 2017

S M Murad-Regadas

3

1 reference

29 November 2017

J A Canedo

4

1 reference

29 November 2017

M Leal

5

1 reference

29 November 2017

J J Nogueras

6

1 reference

29 November 2017

S D Wexner

7

1 reference

29 November 2017

language of work or name

1 reference

1 May 2011

1 reference

29 November 2017

1 reference

29 November 2017

volume

13

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

555-560

1 reference

A prospective audit of the complications of loop ileostomy construction and takedown

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

The risk of post-operative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Mechanism of action of 5-arninosalicylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Factors which influenced postoperative complications in patients with ulcerative colitis or Crohn's disease of the colon on corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Complications of construction and closure of temporary loop ileostomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Comparison of stapled versus handsewn loop ileostomy closure: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Loop ileostomy closure after restorative proctocolectomy: outcome in 1,504 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Loop ileostomy is a safe option for fecal diversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

The impact of preoperative immunomodulation on pouch-related septic complications after ileal pouch-anal anastomosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2010.02186.X

10.1111/J.1463-1318.2010.02186.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference